A non-interventional study of melphalan flufenamide (melflufen, Pepaxti) in combination with dexamethasone in patients with relapsed and/or refractory multiple myeloma (RRMM) according to the approved label.

Authors
Category Primary study
Registry of TrialsGerman Clinical Trials Register
Year 2023
This article has no abstract
Epistemonikos ID: 4b550f1d5a5a6b7690893f2a9b0468ad2e544338
First added on: Apr 10, 2025